SHIONOGI Science Program

Application areas

• An innovative approach to target identification and/or technology platform in drug discovery for pain.
• An innovative approach to discovery of novel opioid analgesics without central side effects, such as psychological dependence, sedation and respiratory depression.
• A unique bioinformatics method to identify novel drug targets, biomarkers and pathogenesis of CNS disorders in emphasis on research to treat impairment of cognitive functions.
• An approach and/or technology to improve gastrointestinal mucosal permeability of beta-lactam antibiotics.
• A novel approach to cure (virus eradication) or to functional cure (permanent suppression of viral replication) of human immunodeficiency virus (HIV) infection.
• A novel approach to cure (virus eradication) or to functional cure (permanent suppression of viral replication) of hepatitis B virus (HBV) infection.
• A preclinical model of latent HIV infection.
• A preclinical model of latent HBV infection.
• A preclinical model of chronic human herpesvirus (HHV) infection.

Application periods

9:00 am 16th January 2017 – 4:00 pm 24th February 2017
(The above dates and times are provided in JST; please check the corresponding dates and times for each country)

Application method

Apply using the “Application Form”.
(Available language is English only.)
Shionogi will inform applicants of receiving application by e-mail within 3 working days.
Applicants, who do not receive an e-mail, should make inquiries via the “Inquiries Form”.

Click here to learn more !

Source : SHIONOGI Science Program